Advisors


Roy Davis

Ex-President, Johnson & Johnson Development Corporation (JJDC), Founder, RedScript Ventures, and Vice President, Corporate Development, Johnson & Johnson.

Davis took over in January 2008 as president of Johnson & Johnson Development Corporation (JJDC), where he directed the creation of RedScript Ventures to support early-stage external ventures andinternal idea incubation.

He also spent the four years as vice-president of corporate development at J&J responsible for acquisition and licensing in areas outside of its business sectors and management of the medical device maker’s wholly-owned ventures as well as corporate venturing before retiring at the end of 2011.

In total, Davis, spent nearly three decades at J&J, having joined in 1984, and worked his way through line leadership positions of increasing responsibility in the organization in the US, Europe and Asia, and then to worldwide franchise chairman for diagnostics in 2003, where he spent the five years before taking JJDC to its next level of development.

These efforts focused on developing new companies for J&J, while he also serves as a member of the industrial advisory board of the Cleveland Clinic and is now on the board of innovation consultancy group Innosight set up to implement the ideas of disruptive innovation by academic Clayton Christensen.

 

Robert J. Easton

For over 30 years, Bob Easton has been recognized as a leader in healthcare business consulting. He has built and led two top firms, beginning with the founding of The Wilkerson Group in 1985. He has led scores of market development and strategic advisory assignments for clients, including large and specialty pharmaceutical companies, early-stage through publicly traded biopharmaceutical companies, and diagnostics businesses. He has influenced the decision-making of numerous healthcare professionals and supported hundreds of client’s executives in Australia, Japan, Canada, U.S., Europe and Israel. His interest in healthcare began when he managed a medical diagnostics business for Union Carbide.